TabletSGLT2 InhibitorsOral
🇮🇳IndiaTablet
FDapa33-Plus
Generic Formulation: Dapagliflozin
Regulatory Registrant: Shilpa Medicare
OralSGLT2 Inhibitors
Pricing & Therapeutic Cost Guide
MRP
₹469.76
10 tablets (per strip)
Indications & Usage
For the treatment of hypertension, heart failure, and diabetic nephropathy. Also used for prevention of stroke and myocardial infarction.
Warnings & Precautions
May cause angioedema. Monitor renal function and potassium levels. Avoid during pregnancy.
Side Effects
May include dry cough, hypotension, dizziness, hyperkalemia, and angioedema (rare).
Drug Interactions
May interact with potassium supplements, NSAIDs, diuretics, and lithium.
Storage & Handling
Store at room temperature. Keep container tightly closed.